期刊文献+

血糖、血压、C反应蛋白及载脂蛋白与脑梗死进展关系探讨

原文传递
导出
摘要 目的探讨血糖、血压、C反应蛋白、载脂蛋白与脑梗死进展的关系。方法对急性脑梗死(ACI)患者入院后行血糖(FBG)、载脂蛋白A(apoA)、载脂蛋白B(apoB)、C反应蛋白(CRP)检查,记录入院时收缩压(SBP),舒张压(DBP)。将FBG分为A组(≤8mmol/L)和B组(>8mmol/L),同样的方法将SBP(≤160mmHg,>160mmHg)、DBP(≤90mmHg,>90mmHg)、CRP(≤10mg/L,>10mg/L)、apoA(≤1·8g/L,>1·8g/L)、apoB(≤1·45g/L,>1·45g/L)各分为A、B两组,每组统计进展性脑梗死(ECI)和稳定性脑梗死(CCI)的例数,计算两组病例中ECI例数占总例数的比率(脑梗死进展率,ER)。用SPSS10·0统计软件对每项参数A、B组间ER逐一进行χ2检验,计算B组增加的脑梗死进展危险率(△ERCI)。△ERCI=(ERB-ERA)/ERA×100%。结果FBG、DBP、CRP、apoB等4项A、B组间ER差异有统计学意义,P<0·05。其中,FBG>8mmol/L、CRP>10mg/L、apoB>1·45g/L组相应地比FBG≤8mmol/L、CRP≤10mg/L、apoB≤1·45g/L组ER高,各增加67·3%、114·3%、92·9%。而DBP>90mmHg组比DBP≤90mmHg组脑梗死进展率下降,减少41·6%。结论入院时FBG、CRP、apoB升高和DBP下降的ACI病例更有进展的倾向,可作为进展的预测指标。
出处 《临床医学》 CAS 2005年第9期22-23,共2页 Clinical Medicine
基金 温州市卫生局基金资助项目(2002012)
  • 相关文献

参考文献11

  • 1陆紫敏,朱海平,孙向华.载脂蛋白B对急性脑梗死患者的影响[J].中国实用内科杂志,2000,20(7):432-433. 被引量:11
  • 2王文化,赵冬,吴桂贤,刘军,姚丽,吴兆苏.北京市1984~1999年人群脑卒中发病率变化趋势分析[J].中华流行病学杂志,2001,22(4):269-272. 被引量:157
  • 3温红梅.C反应蛋白与缺血性卒中[J].国外医学(脑血管疾病分册),2002,10(4):298-300. 被引量:102
  • 4饶明俐.脑血管疾病[A].见:侯熙德主编.神经病学:第3版[C].北京:人民卫生出版社,2000.108-136.
  • 5Terai S. Clinical course of acute deep infarcts in carotid system - pathogenesis of progressing stroke. Nippn - Ronen - Igakkai - Zasshi, 1999,36(11) :811 -816.
  • 6Barber M, Langhorne P, Rumley A, et al. Hemostatic function and progressing ischemic stroke: D -dimer predicts early clinical progression.Stroke,2004,35 (6): 1421 - 1425.
  • 7Licata G,Tuttolomondo A, Sinagra D, et al. Diabetes mellitus and stroke.Ital Heart J Suppl, 2002,3 ( 5 ) :471 - 477.
  • 8Gadre E, Lassen NA. Apoplexy with rapidly deteriorating symptoms -"stroke in progression". Hemodynamic and clinical aspects. Ugeskr - Laeger, 1995,157 (30) :4234 - 4239.
  • 9Ho CH,Hu HH,Wong WJ. The serial hemostasis - related changes in pa tients with cerebral infarction:comparison between progressing and non progressing stroke. Thromb - Res, 1989,56 (5) :635 - 647.
  • 10Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet, 1997,349 (9045) :79 - 83.

二级参考文献26

  • 1叶平,陈保生,王士雯.应用聚合酶链反应研究载脂蛋白B基因多态性及其临床意义[J].中华医学检验杂志,1994,17(1):7-11. 被引量:17
  • 2李健斋,中华医学检验杂志,1994年,17卷,1期,5页
  • 3Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor.more than an epiphenomenon? Circulation,1999, 100(1 ): 96-102.
  • 4Tracy RP. Inflammation in cardiovascular disease: cart, horse, or both.? Circulation, 1998, 97(20): 2000-2002.
  • 5Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem, 1999, 45 (12):2136-2141.
  • 6Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem, 2001,47(3):418-425.
  • 7Meier-Ewert HK, Ridker PM, Rifai N, et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.Clin Chem, 2001,47(3): 426-430.
  • 8Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin,and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997, 336(14): 973-979.
  • 9Di Napoli M, Di Gianfilippa G, Sollecito A, et al. C-reactive protein and outcome after first-ever ischemic stroke. Stroke, 2000, 31 (1):238-239.
  • 10Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke,2001,32(1): 133-138.

共引文献268

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部